CAS 157263-00-8
:MK 996
Description:
MK 996, also known by its CAS number 157263-00-8, is a chemical compound that belongs to the class of selective serotonin reuptake inhibitors (SSRIs). It is primarily investigated for its potential therapeutic effects in treating various mood disorders, including depression and anxiety. The compound functions by modulating serotonin levels in the brain, which can help improve mood and emotional balance. MK 996 exhibits a specific mechanism of action that targets serotonin transporters, thereby enhancing serotonin availability in synaptic clefts. In terms of physical properties, MK 996 is typically characterized by its molecular structure, which includes specific functional groups that contribute to its pharmacological activity. Safety and toxicity profiles are essential considerations in its development, and ongoing research aims to elucidate its efficacy and side effects in clinical settings. As with any pharmaceutical compound, regulatory approval and thorough clinical testing are crucial steps before it can be widely used in medical practice.
Formula:C30H28N4O3S
InChI:InChI=1/C30H28N4O3S/c1-4-27-32-28-20(2)18-21(3)31-29(28)34(27)19-22-14-16-23(17-15-22)25-12-8-9-13-26(25)38(36,37)33-30(35)24-10-6-5-7-11-24/h5-18H,4,19H2,1-3H3,(H,33,35)
SMILES:CCc1nc2c(C)cc(C)nc2n1Cc1ccc(cc1)c1ccccc1S(=O)(=O)N=C(c1ccccc1)O
Synonyms:- 3-((2'-(Benzoylaminosulfonyl)biphenyl-4-yl)methyl)-2-ethyl-5,7-dimethyl-3H-imidazo(4,5-b)pyridine
- L 159282
- Benzamide, N-((4'-((2-ethyl-5,7-dimethyl-3H-imidazo(4,5-b)pyridin-3-yl)methyl)(1,1'-biphenyl)-2-yl)sulfonyl)-
- N-({4'-[(2-ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl)methyl]biphenyl-2-yl}sulfonyl)benzamide
- MK-996
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
N-((4-((2-Ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl)methyl)-[1,1'-biphenyl]-2-yl)sulfonyl)benzamide
CAS:Formula:C30H28N4O3SMolecular weight:524.63333-((2'-(Benzoylaminosulfonyl)biphenyl-4-yl)methyl)-2-ethyl-5,7-dimethyl-3H-imidazo(4,5-B)pyridine
CAS:<p>3-((2'-(Benzoylaminosulfonyl)biphenyl-4-yl)methyl)-2-ethyl-5,7-dimethyl-3H-imidazo(4,5-B)pyridine is an at1 receptor antagonist that has been shown to be an orally active drug with a pressor effect. This compound inhibits the binding of neurokinin 1 to its receptor, leading to vasodilation and reduced blood pressure. 3-(2'-benzoylaminosulfonyl)biphenyl-4-ylmethyl)-2-ethyl-5,7-dimethyl-3H-[imidazo(4,5,-B)]pyridine has also been shown to have antihypertensive activity in animal models. The pharmacokinetics of 3-(2'-benzoylaminosulfonyl)biphenyl--4--ylmethyl)-2--ethyl--5,7--dim</p>Formula:C30H28N4O3SPurity:Min. 95%Molecular weight:524.6 g/molL-159282
CAS:<p>L-159282 is an orally active and nonpeptide angiotensin II receptor antagonist. It also has anti-hypertensive activity.</p>Formula:C30H28N4O3SPurity:98%Color and Shape:SolidMolecular weight:524.63


